Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ACYCLOVIR | 400MG | TABLET | Resolved | 2017-11-16 | 2018-11-09 | 29444 |
| TEVA-ACYCLOVIR | 400MG | TABLET | Resolved | 2019-08-22 | 2019-10-04 | 92137 |
| TEVA-ACYCLOVIR | 200MG | TABLET | Resolved | 2020-07-16 | 2020-07-30 | 120450 |
| TEVA-ACYCLOVIR | 400MG | TABLET | Resolved | 2020-08-20 | 2025-04-29 | 122712 |
| TEVA-ACYCLOVIR | 200MG | TABLET | Resolved | 2021-06-03 | 2025-04-29 | 140402 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2023-10-19 | 2023-12-07 | 207524 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2020-01-17 | 2020-02-07 | 103569 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2017-05-23 | 2017-09-19 | 10886 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2020-03-12 | 2020-05-14 | 108613 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2022-04-21 | 2022-08-20 | 159195 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2022-05-12 | 2022-08-20 | 160439 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2018-03-16 | 2018-10-11 | 43116 |
| TEVA-ALENDRONATE | 70MG | TABLET | Resolved | 2019-08-22 | 2019-11-01 | 92174 |
| TEVA-ALENDRONATE/CHOLECALCIFEROL | 70MG 2800UNIT | TABLET | Actual shortage | 2017-09-22 | 2018-12-21 | 23143 |
| TEVA-ALENDRONATE/CHOLECALCIFEROL | 70MG 5600UNIT | TABLET | Actual shortage | 2017-09-22 | 2018-12-21 | 23146 |
| TEVA-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2017-08-21 | 2019-08-29 | 19922 |
| TEVA-ALMOTRIPTAN | 12.5MG | TABLET | Actual shortage | 2024-06-07 | 2024-08-08 | 229966 |
| TEVA-ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2023-01-12 | 2023-06-21 | 180894 |
| TEVA-ALPRAZOLAM | 0.5MG | TABLET | Resolved | 2023-01-12 | 2023-04-28 | 180897 |
| TEVA-AMIODARONE | 200MG | TABLET | Resolved | 2022-06-16 | 2022-09-23 | 162849 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| ACT OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |
| ACT OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |
| ACT OLMESARTAN HCT | 40MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117516 |
| ACT OLMESARTAN HCT | 20MG 12.5MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117513 |
| ACT OLMESARTAN HCT | 40MG 25MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117519 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
| ACT OXYCODONE CR | 5MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-22 | 2018-10-22 | 65328 |
| ACT PROGESTERONE INJECTION | 50MG | SOLUTION | Discontinued | 2025-04-29 | 2025-04-29 | 256082 |